|Podcasts|September 13, 2021
From Lab to Life: Accelerating End-to-End Drug Development to Bring Medicines to Patients Faster
Author(s)Syneos Health
In Episode Two of the Syneos Health Dedicated Dialogue podcast series, we reveal how harnessing broad expertise across the product development lifecycle leads to relevant, effective and efficient solutions that speed commercial success and bring novel drugs to patients sooner to improve patient care.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report
2
Gilead Sciences Enters $2.1 Billion Definitive Agreement to Acquire Ouro Medicines
3
Why CMS Is Tightening ASP Reporting and What Manufacturers Must Get Right
4
Pharmaceutical Executive Daily: Pfizer Warns Shareholders to Reject Mini-Tender Offer
5